Faratian, D: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 network

Galina Lebedeva, Anatoly Sorokin, Dana Faratian, Peter Mullen, Alexey Goltsov, Simon P. Langdon, David J. Harrison, Igor Goryanin

Journal:

European Journal of Pharmaceutical Sciences

Year:

2012

Language:

english

File:

PDF, 1.61 MB

english, 2012

2

What can molecular pathology contribute to the management of renal cell carcinoma?

Stewart, Grant D., O'Mahony, Fiach C., Powles, Thomas, Riddick, Antony C. P., Harrison, David J., Faratian, Dana

Journal:

Nature Reviews Urology (formerly Nature Clinical Practice Urology)

Year:

2011

Language:

english

File:

PDF, 1.20 MB

english, 2011

3

GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines

Kevin Morgan, Colette Meyer, Nicola Miller, Andrew H Sims, Ilgin Cagnan, Dana Faratian, David J Harrison, Robert P Millar, Simon P Langdon

Journal:

Year:

2011

Language:

english

File:

PDF, 836 KB

english, 2011

4

General anesthesia for intrauterine placement of human conceptuses after in vitro fertilization

Simon Fishel, J. Webster, B. Faratian, P. Jackson

Journal:

Journal of Assisted Reproduction and Genetics

Year:

1987

Language:

english

File:

PDF, 417 KB

english, 1987

5

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

Johanna G. H. van Nes, Esther M. de Kruijf, Dana Faratian, Cornelis J. H. van de Velde, Hein Putter, Claire Falconer, Vincent T. H. B. M. Smit, Charlene Kay, Marc J. van de Vijver, Peter J. K. Kuppen,

Journal:

Breast Cancer Research and Treatment

Year:

2011

Language:

english

File:

PDF, 520 KB

english, 2011

6

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

E. J. Macaskill, J. M. S. Bartlett, V. S. Sabine, D. Faratian, L. Renshaw, S. White, F. M. Campbell, O. Young, L. Williams, J. S. Thomas, M. D. Barber, J. M. Dixon

Journal:

Breast Cancer Research and Treatment

Year:

2011

Language:

english

File:

PDF, 316 KB

english, 2011

7

Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer

Sylvie Dubois-Marshall, Jeremy S. Thomas, Dana Faratian, David J. Harrison, Elad Katz

Journal:

Clinical and Experimental Metastasis

Year:

2011

Language:

english

File:

PDF, 546 KB

english, 2011

8

Predictive markers in breast cancer – the future

D Faratian, J Bartlett

Journal:

Year:

2008

Language:

english

File:

PDF, 83 KB

english, 2008

9

Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization

A D Graham, D Faratian, F Rae, J St J Thomas

Journal:

Year:

2008

Language:

english

File:

PDF, 90 KB

english, 2008

10

Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma

Dana Faratian, Alison Munro, Christopher Twelves, John MS Bartlett

Journal:

Year:

2009

Language:

english

File:

PDF, 112 KB

english, 2009

11

Pleural Wegener’s granulomatosis: a rare presentation

Dana Faratian, Bonnie Marr, Friederike Böllert, Raashid Luqmani, Donald Salter, William Wallace

Journal:

Year:

2009

Language:

english

File:

PDF, 305 KB

english, 2009

12

Rapid screening of tissue microarrays for Her-2 fluorescence in situ hybridization testing is an accurate, efficient and economic method of providing an entirely in situ hybridization-based Her-2 testing service

Dana Faratian, Ashley Graham, Frances Rae, Jeremy Thomas

Journal:

Year:

2009

Language:

english

File:

PDF, 104 KB

english, 2009

13

Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: The TEAM Trial Experience

Dana Faratian, Charlene Kay, Tammy Robson, Fiona M Campbell, Margaret Grant, Dan Rea, John M S Bartlett

Journal:

Year:

2009

Language:

english

File:

PDF, 173 KB

english, 2009

14

Validation of activated caspase-3 antibody staining as a marker of apoptosis in breast cancer

Vicky S Sabine, Dana Faratian, Tove Kirkegaard-Clausen, John MS Bartlett

Journal:

Year:

2012

Language:

english

File:

PDF, 385 KB

english, 2012

15

Levels of circulating immune complexes in patients with ovarian cancer

ANN G. CLARKE, D. P. VASEY, E. M. SYMONDS, B. FARATIAN, P. J. McLAUGHLIN, M. R. PRICE, R. W. BALDWIN

Journal:

BJOG: An International Journal of Obstetrics & Gynaecology

Year:

1982

Language:

english

File:

PDF, 550 KB

english, 1982

16

Effect on low implantation of the placenta on maternal blood pressure and placental function

K. H. NICOLAIDES, B. FARATIAN, E. M. SYMONDS

Journal:

BJOG: An International Journal of Obstetrics & Gynaecology

Year:

1982

Language:

english

File:

PDF, 332 KB

english, 1982

17

The use of the GnRH analogue buserelin for IVF—does it improve fertility?

KAREN SHELTON, SIMON FISHEL, PETER JACKSON, JOHN WEBSTER, BAHMAN FARATIAN, JOANNE JOHNSON

Journal:

BJOG: An International Journal of Obstetrics & Gynaecology

Year:

1991

Language:

english

File:

PDF, 376 KB

english, 1991

18

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

D. FARATIAN, A. STILLIE, R.M. C. BUSBY-EARLE, V.J. COWIE, H. MONAGHAN

Journal:

International Journal of Gynecological Cancer

Year:

2006

Language:

english

File:

PDF, 253 KB

english, 2006

19

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

Katz, E, Dubois-Marshall, S, Sims, A H, Faratian, D, Li, J, Smith, E S, Quinn, J A, Edward, M, Meehan, R R, Evans, E E

Journal:

British Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 840 KB

english, 2010

20

Dynamic changes in gene expressionin vivopredict prognosis of tamoxifen-treated patients with breast cancer

Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, Simon P Langdon

Journal:

Breast Cancer Research

Year:

2010

Language:

english

File:

PDF, 2.01 MB

english, 2010

21

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients

Johanna G. H. van Nes, Esther M. de Kruijf, Hein Putter, Dana Faratian, Alison Munro, Fiona Campbell, Vincent T. H. B. M. Smit, Gerrit-Jan Liefers, Peter J. K. Kuppen, Cornelis J. H. van de Velde, Joh

Journal:

Breast Cancer Research and Treatment

Year:

2012

Language:

english

File:

PDF, 580 KB

english, 2012

22

Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibition

Alexey Goltsov, Dana Faratian, Simon P. Langdon, James Bown, Igor Goryanin, David J. Harrison

Journal:

Cellular Signalling

Year:

2011

Language:

english

File:

PDF, 487 KB

english, 2011

23

Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition

Alexey Goltsov, Dana Faratian, Simon P. Langdon, Peter Mullen, David J. Harrison, James Bown

Journal:

Cellular Signalling

Year:

2012

Language:

english

File:

PDF, 844 KB

english, 2012

24

Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

O.E. Young, L. Renshaw, E.J. Macaskill, S. White, D. Faratian, J.St.J. Thomas, J.M. Dixon

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 177 KB

english, 2008

25

Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapy

Dana Faratian, InHwa Um, Danielle S. Wilson, Peter Mullen, Simon P. Langdon, David J. Harrison

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 1.16 MB

english, 2011

26

DCIS and aromatase inhibitors

J. Michael Dixon, Dana Faratian, Sharon White, Lorna Renshaw, Juliette Murray, Oliver Young, E. Jane Macaskill, Linda Williams, Jeremy Thomas, Dean B. Evans

Journal:

The Journal of Steroid Biochemistry and Molecular Biology

Year:

2007

Language:

english

File:

PDF, 621 KB

english, 2007

27

HER2 expression in ovarian carcinoma: caution and complexity in biomarker analysis

McCaughan, H., Um, I., Langdon, S. P., Harrison, D. J., Faratian, D.

Journal:

Journal of Clinical Pathology

Year:

2012

Language:

english

File:

PDF, 177 KB

english, 2012

28

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases

Aitken, S. J., Thomas, J. S., Langdon, S. P., Harrison, D. J., Faratian, D.

Journal:

Annals of Oncology

Year:

2010

Language:

english

File:

PDF, 859 KB

english, 2010

29

Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF- B survival signatures following GNRH receptor activation

Meyer, C., Sims, A. H., Morgan, K., Harrison, B., Muir, M., Bai, J., Faratian, D., Millar, R. P., Langdon, S. P.

Journal:

Endocrine Related Cancer

Year:

2013

Language:

english

File:

PDF, 1.74 MB

english, 2013

30

Feedforward and feedback regulation of the MAPK and PI3K oscillatory circuit in breast cancer

Huizhong Hu, Alexey Goltsov, James L. Bown, Andrew H. Sims, Simon P. Langdon, David J. Harrison, Dana Faratian

Journal:

Cellular Signalling

Year:

2013

Language:

english

File:

PDF, 1.17 MB

english, 2013

31

Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): results from a randomised trial

O. Young, Faratian, S. White, J. Murray, L. Renshaw, J. Macaskill, D. Evans, D. Cameron, W. Miller, M. Dixon

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 125 KB

english, 2006

32

Randomized pre-operative study of 750 mg of fulvestrant and 20 mg tamoxifen in premenopausal women with estrogen receptor-positive breast cancer

O. Young, Renshaw, S. White, J. Macaskill, D. Cameron, J. Thomas, D. Faratian, M. Dixon

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 254 KB

english, 2006

33

O-99 The mTOR (mammalian target of rapamycin) inhibitor RAD001 (Everolimus) is safe and reduces proliferation in postmenopausal women with breast cancer

E.J. Macaskill, J.M.S. Bartlett, L. Renshaw, D. Faratian, S. White, F.M. Campbell, O. Young, M. Stumm, J. Thomas, M.D. Barber, J.M. Dixon

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 43 KB

english, 2007

34

Delivery of twins to a woman with surgical induced menopause after oocyte donation by the sister and cryopreservation of the conceptuses

S Fischel, J Webster, B Faratian, P Jackson

Journal:

International Journal of Gynecology & Obstetrics

Year:

1989

Language:

english

File:

PDF, 133 KB

english, 1989

35

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

H.C. Pedersen, R. Ventura, D. Faratian, U. Chetty, J.M. Dixon, W. Jack, G. Kerr, I. Kunkler, J.M.S. Bartlett

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 60 KB

english, 2008

36

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

Sims, A H, Zweemer, A JM, Nagumo, Y, Faratian, D, Muir, M, Dodds, M, Um, I, Kay, C, Hasmann, M, Harrison, D J, Langdon, S P

Journal:

British Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 714 KB

english, 2012

37

Systems pathology—taking molecular pathology into a new dimension

Faratian, Dana, Clyde, Robert G., Crawford, John W., Harrison, David J.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2009

Language:

english

File:

PDF, 480 KB

english, 2009

38

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Moleirinho, S, Chang, N, Sims, A H, Tilston-Lünel, A M, Angus, L, Steele, A, Boswell, V, Barnett, S C, Ormandy, C, Faratian, D, Gunn-Moore, F J, Reynolds, P A

Journal:

Year:

2013

Language:

english

File:

PDF, 3.90 MB

english, 2013

39

Systems pathology

Journal:

Breast Cancer Research

Year:

2010

Language:

english

File:

PDF, 144 KB

english, 2010

40

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

E Katz, D Faratian, JMS Bartlett, K MacLeod, H Pedersen…

Journal:

Breast Cancer Research

Year:

2008

Language:

english

File:

PDF, 2.44 MB

english, 2008

41

Dynamic computational modeling in the search for better breast cancer drug therapy

Faratian, Dana, Moodie, Stuart L, Harrison, David J, Goryanin, Igor

Journal:

Pharmacogenomics

Year:

2007

Language:

english

File:

PDF, 158 KB

english, 2007

42

Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer

Argenta, Peter A., Um, Inhwa, Kay, Charlene, Harrison, David, Faratian, Dana, Sueblinvong, Thanasak, Geller, Melissa A., Langdon, Simon P.

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 445 KB

english, 2013

43

Reply

Faratian, B., O'Brien, P.M.S., Filshie, G.M.

Journal:

American Journal of Obstetrics and Gynecology

Year:

1985

Language:

english

File:

PDF, 456 KB

english, 1985

44

Subzonal insemination

Fishel, S., Timson, J., Faratian, B., Symonds, E.M.

Journal:

Year:

1992

Language:

english

File:

PDF, 321 KB

english, 1992

45

PLACE OF GIFT IN INFERTILITY SERVICES

Fishel, S, Webster, J, Faratian, B, Jackson, P, Yovich, JohnL, Draper, RoganR, Yovich, JeanneM, Rohini Edirisinghe, W, Cummins, JamesM

Journal:

Year:

1988

Language:

english

File:

PDF, 181 KB

english, 1988

46

ALTERED SEX RATIOS

Tampi, Ram, Swann, Ron, Fishel, S., Webster, J., Jackson, P., Faratian, B., Shelton, K., Johnson, J., D'Souza, S.W., Rivlin, E.

Journal:

Year:

1989

Language:

english

File:

PDF, 311 KB

english, 1989

47

Premenstrual syndrome: Weight, abdominal swellin, and Perceived body image

Faratian, B., Gaspar, A., O'Brien, P.M.S., Johnson, I.R., Filshie, G.M., Prescott, P.

Journal:

American Journal of Obstetrics and Gynecology

Year:

1984

Language:

english

File:

PDF, 6.60 MB

english, 1984

48

PRESENTATION OF INFORMATION ON IN-VITRO FERTILISATION

Fishel, S., Webster, J., Jackson, P., Faratian, B.

Journal:

Year:

1986

Language:

english

File:

PDF, 158 KB

english, 1986

49

Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab

Faratian, D., Goltsov, A., Lebedeva, G., Sorokin, A., Moodie, S., Mullen, P., Kay, C., Um, I. H., Langdon, S., Goryanin, I., Harrison, D. J.

Journal:

Cancer Research

Year:

2009

Language:

english

File:

PDF, 571 KB

english, 2009

50

Pertuzumab for the treatment of ovarian cancer

Langdon, Simon P, Faratian, Dana, Nagumo, Yoko, Mullen, Peter, Harrison, David J

Journal:

Expert Opinion on Biological Therapy

Year:

2010

Language:

english

File:

PDF, 222 KB

english, 2010

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски